Bleeding DisordersBleeding disorders may be due to a variety of abnormalities of coagulation. Initial laboratory testing consists of a prothrombin time (PT), partial thromboplastin time (PTT) and platelet count (part of a CBC). Common causes for an abnormal PT include disorders affecting coagulation factors II, V, VII, and X that are synthesized in the liver and are vitamin K dependent (vitamin K carboxylates glutamate residues). Thus, liver disease and coumadin therapy will prolong the PT. Common causes for an abnormal PTT include deficiencies in factors II, V, VIII, IX, X, XI, and XII. This includes hemophilia A (diminished factor VIII activity), hemophilia B (decreased factor IX), and heparin therapy. Abnormalities in platelet numbers (thrombocytopenia) may be due to decreased marrow production (aplastic anemia) or increased peripheral consumption (secondary hypersplenism, anti-platelet antibodies [ITP], microangiopathic hemolytic anemias [DIC, TTP]). Platelet FunctionAbnormalities in platelet function must be considered when the platelet count is normal. The bleeding time is increased, but a more useful analysis is a platelet function analysis (PFA). A sample of platelets is placed into a platelet function analysis instrument that usually measures the aggregation of platelets in response to an added stimulatory agent, and the response measured by an increase in turbidity with diminished light transmission, plotted on a graph. The appearance of the graph can be used to determine different types of platelet function problems. The normal response of platelets to ADP is shown below at the left. Note that when ADP is added (indicated by the spike) there is an initial small upward curve as platelets undergo shape change, followed by a progressive downward curve from the primary wave of aggregation to a small plateau. At this point the secondary wave of platelet aggregation begins, followed by another downward curve. The graph of platelet response to epinephrine below at the right shows no initial upward peak from shape change, but there is a similar primary wave of aggregation followed by a plateau and then a secondary wave of aggregation.
In response to addition of collagen, the graph below at the left illustrates a short lag before a peak from shape change occurred, followed by a single wave of aggregation. The graph at the right below shows that the curve following addition of thrombin is similar, but without an initial lag.
The graph of platelet response to ristocetin shows an immediate single wave of aggregation, without shape change. Abnormal Conditions
|
|